341 related articles for article (PubMed ID: 17119032)
41. Combined effect of volumetric breast density and body mass index on breast cancer risk.
Engmann NJ; Scott CG; Jensen MR; Winham S; Miglioretti DL; Ma L; Brandt K; Mahmoudzadeh A; Whaley DH; Hruska C; Wu F; Norman AD; Hiatt RA; Heine J; Shepherd J; Pankratz VS; Vachon CM; Kerlikowske K
Breast Cancer Res Treat; 2019 Aug; 177(1):165-173. PubMed ID: 31129803
[TBL] [Abstract][Full Text] [Related]
42. Association between mammographic density and pregnancies relative to age and BMI: a breast cancer case-only analysis.
Hack CC; Emons J; Jud SM; Heusinger K; Adler W; Gass P; Haeberle L; Heindl F; Hein A; Schulz-Wendtland R; Uder M; Hartmann A; Beckmann MW; Fasching PA; Pöhls UG
Breast Cancer Res Treat; 2017 Dec; 166(3):701-708. PubMed ID: 28828694
[TBL] [Abstract][Full Text] [Related]
43. Type 2 diabetes and mammographic breast density among underserved women.
Sanderson M; O'Hara H; Foderingham N; Dupont WD; Shu XO; Peterson N; Fair AM; Disher AC
Cancer Causes Control; 2015 Feb; 26(2):303-309. PubMed ID: 25421380
[TBL] [Abstract][Full Text] [Related]
44. Mammographic density as a risk factor for breast cancer in a German case-control study.
Heusinger K; Loehberg CR; Haeberle L; Jud SM; Klingsiek P; Hein A; Bayer CM; Rauh C; Uder M; Cavallaro A; May MS; Adamietz B; Schulz-Wendtland R; Wittenberg T; Wagner F; Beckmann MW; Fasching PA
Eur J Cancer Prev; 2011 Jan; 20(1):1-8. PubMed ID: 21102341
[TBL] [Abstract][Full Text] [Related]
45. Different types of postmenopausal hormone therapy and mammographic density in Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Lund E; Gram IT
Int J Cancer; 2007 Feb; 120(4):880-4. PubMed ID: 17131324
[TBL] [Abstract][Full Text] [Related]
46. The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.
McCarthy AM; Keller B; Kontos D; Boghossian L; McGuire E; Bristol M; Chen J; Domchek S; Armstrong K
Breast Cancer Res; 2015 Jan; 17(1):1. PubMed ID: 25567532
[TBL] [Abstract][Full Text] [Related]
47. Using mammographic density to improve breast cancer screening outcomes.
Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer risk factors and mammographic breast density in women over age 70.
Modugno F; Ngo DL; Allen GO; Kuller LH; Ness RB; Vogel VG; Costantino JP; Cauley JA
Breast Cancer Res Treat; 2006 May; 97(2):157-66. PubMed ID: 16362132
[TBL] [Abstract][Full Text] [Related]
49. Childhood body size and pubertal timing in relation to adult mammographic density phenotype.
Schoemaker MJ; Jones ME; Allen S; Hoare J; Ashworth A; Dowsett M; Swerdlow AJ
Breast Cancer Res; 2017 Feb; 19(1):13. PubMed ID: 28173872
[TBL] [Abstract][Full Text] [Related]
50. Fertility drug use and mammographic breast density in a mammography screening cohort of premenopausal women.
Sprague BL; Trentham-Dietz A; Terry MB; Nichols HB; Bersch AJ; Buist DS
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3128-33. PubMed ID: 18990754
[TBL] [Abstract][Full Text] [Related]
51. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort.
Vachon CM; Kushi LH; Cerhan JR; Kuni CC; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):151-60. PubMed ID: 10698475
[TBL] [Abstract][Full Text] [Related]
52. A longitudinal study of the effects of menopause on mammographic features.
Boyd N; Martin L; Stone J; Little L; Minkin S; Yaffe M
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1048-53. PubMed ID: 12376506
[TBL] [Abstract][Full Text] [Related]
53. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
[TBL] [Abstract][Full Text] [Related]
54. Associations of mammographic density with dietary factors in Japanese women.
Nagata C; Matsubara T; Fujita H; Nagao Y; Shibuya C; Kashiki Y; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2877-80. PubMed ID: 16365004
[TBL] [Abstract][Full Text] [Related]
55. Long-term prognostic implications of risk factors associated with tumor size: a case study of women regularly attending screening.
Strand F; Humphreys K; Holm J; Eriksson M; Törnberg S; Hall P; Azavedo E; Czene K
Breast Cancer Res; 2018 Apr; 20(1):31. PubMed ID: 29669579
[TBL] [Abstract][Full Text] [Related]
56. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
57. A prospective study of breast cancer risk using routine mammographic breast density measurements.
Vacek PM; Geller BM
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):715-22. PubMed ID: 15159301
[TBL] [Abstract][Full Text] [Related]
58. Mammographic density and risk of breast cancer in Korean women.
Kim BK; Choi YH; Nguyen TL; Nam SJ; Lee JE; Hopper JL; Sung J; Song YM
Eur J Cancer Prev; 2015 Sep; 24(5):422-9. PubMed ID: 25370685
[TBL] [Abstract][Full Text] [Related]
59. Breast Cancer Risk Associations with Digital Mammographic Density by Pixel Brightness Threshold and Mammographic System.
Nguyen TL; Choi YH; Aung YK; Evans CF; Trinh NH; Li S; Dite GS; Kim MS; Brennan PC; Jenkins MA; Sung J; Song YM; Hopper JL
Radiology; 2018 Feb; 286(2):433-442. PubMed ID: 29040039
[TBL] [Abstract][Full Text] [Related]
60. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
